Vazirani Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-350,000
Closed -$1.06M 26
2024
Q4
$1.06M Buy
350,000
+250,000
+250% +$760K 3.3% 7
2024
Q3
$519K Buy
+100,000
New +$519K 0.92% 18